Protera
Guillaume Baxter is an experienced venture capital professional currently serving as a Partner and Principal at Sofinnova Partners since May 2017, focusing on early-stage investments in renewable-based chemistries, industrial biotechnologies, foodtech, and agbiotech across Europe and North America. In addition, Guillaume holds multiple board member and observer positions at various companies, including GFBiochemicals, Qorium, Micropep Technologies, Bon Vivant, Protera Biosciences, Meiogenix, and DNA Script. Previous experience includes roles at Solvay Ventures, where responsibilities encompassed European direct investment activities and collaboration with Sofinnova Partners' industrial biotechnology team, as well as research activities focused on microbial physiology at CNRS. Educational credentials include advanced degrees in biotechnology, innovation management, and related fields from prestigious institutions such as Université de Technologie de Compiègne and Université Paris Cité.
This person is not in any teams
This person is not in any offices
Protera
1 followers
Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.